Earnings per share (Tables)

12 Months Ended

Dec. 31, 2021

Earnings per share [abstract]

Earnings per share

	2021	2020	2019
Net income attributable to shareholders of Novartis AG (USD millions)
- Continuing operations	24 021	8 072	7 142
- Discontinued operations			4 590
Total	24 021	8 072	11 732
Number of shares (in millions)
Weighted average number of shares outstanding used in basic earnings per share	2 243	2 277	2 291
Adjustment for vesting of restricted shares, restricted share units and dilutive shares from options	17	19	28
Weighted average number of shares in diluted earnings per share	2 260	2 296	2 319
Basic earnings per share (USD)
- Continuing operations	10.71	3.55	3.12
- Discontinued operations			2.00
Total	10.71	3.55	5.12
Diluted earnings per share (USD)
- Continuing operations	10.63	3.52	3.08
- Discontinued operations			1.98
Total	10.63	3.52	5.06